TY - JOUR
T1 - Viral co-pathogens in COVID-19 acute respiratory syndrome – what did we learn from the first year of pandemic?
AU - Kriger, Or
AU - Gefen-Halevi, Shiraz
AU - Leshem, Eyal
AU - Smollan, Gillian
AU - Belausov, Natasha
AU - Egbarye, Aseel
AU - Khashab, Rawan
AU - Odeh, Miran
AU - Saffia, Adleen
AU - Barak, Yuval
AU - Hussein, Oswa Abu
AU - Hamias, Rachel
AU - Aharon, Yael
AU - Alfandari, Jacqueline
AU - Nemet, Ital
AU - Kliker, Limor
AU - Sherbany, Hilda
AU - Mandelboim, Michal
AU - Amit, Sharon
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2022/3
Y1 - 2022/3
N2 - Objective: : This study aimed to describe the distribution of respiratory pathogens and the occurrence of co-pathogens during the first year of the COVID-19 pandemic. Methods: We used a multiplex polymerase chain reaction (PCR) panel targeting 23 microorganisms to analyze the oro-pharyngeal samples of patients admitted to our hospital with acute respiratory infection (ARI) between March 1, 2020, and February 28, 2021. We matched 40 to 50 patients who were SARS-CoV-2 positive and SARS-CoV-2 negative per month for age and sex. Results: A total of 939 patients with multiplex PCR test results were included in the study. Respiratory pathogens where detected in only 8/476 (1.6%) patients with COVID-19 versus 87/463 (18.7%) patients with non–COVID-19 ARI patients. Diversity and rates of pathogens vastly differed from previous years but showed seasonal variance. Conclusion: Patients with SARS-CoV-2 infection presenting with ARI during the first year of the COVID-19 pandemic demonstrated paucity of respiratory co-pathogens.
AB - Objective: : This study aimed to describe the distribution of respiratory pathogens and the occurrence of co-pathogens during the first year of the COVID-19 pandemic. Methods: We used a multiplex polymerase chain reaction (PCR) panel targeting 23 microorganisms to analyze the oro-pharyngeal samples of patients admitted to our hospital with acute respiratory infection (ARI) between March 1, 2020, and February 28, 2021. We matched 40 to 50 patients who were SARS-CoV-2 positive and SARS-CoV-2 negative per month for age and sex. Results: A total of 939 patients with multiplex PCR test results were included in the study. Respiratory pathogens where detected in only 8/476 (1.6%) patients with COVID-19 versus 87/463 (18.7%) patients with non–COVID-19 ARI patients. Diversity and rates of pathogens vastly differed from previous years but showed seasonal variance. Conclusion: Patients with SARS-CoV-2 infection presenting with ARI during the first year of the COVID-19 pandemic demonstrated paucity of respiratory co-pathogens.
KW - COVID-19
KW - SARS-CoV-2
KW - co-infections
UR - http://www.scopus.com/inward/record.url?scp=85123950164&partnerID=8YFLogxK
U2 - 10.1016/j.ijid.2022.01.018
DO - 10.1016/j.ijid.2022.01.018
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35038602
AN - SCOPUS:85123950164
SN - 1201-9712
VL - 116
SP - 226
EP - 229
JO - International Journal of Infectious Diseases
JF - International Journal of Infectious Diseases
ER -